(Q33297944)

25 July 2017

title

Moving toward individualized therapy based on NER polymorphisms that predict platinum sensitivity in ovarian cancer patients (English)

1 reference

25 July 2017

1 reference

1 reference

7

Michele Follen

1 reference

25 July 2017

2

Karen H Lu

1 reference

25 July 2017

J Salvador Saldivar

1

1 reference

25 July 2017

Dong Liang

3

1 reference

25 July 2017

Jian Gu

4

1 reference

25 July 2017

Maosheng Huang

5

1 reference

25 July 2017

Anne-Therese Vlastos

6

1 reference

25 July 2017

Xifeng Wu

8

1 reference

25 July 2017

language of work or name

English

0 references

publication date

6 September 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

107

1 reference

25 July 2017

issue

1 Suppl 1

1 reference

25 July 2017

page(s)

S223-9

1 reference

25 July 2017

cites work

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

Treatment goals in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

Clinical reversal of drug resistance in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

The major adduct of the antitumor drug cis-diamminedichloroplatinum(II) with DNA bends the duplex by approximately equal to 40 degrees toward the major groove

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

Cancer from the outside, aging from the inside: mouse models to study the consequences of defective nucleotide excision repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

How nucleotide excision repair protects against cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

Nucleotide excision repair and human syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

Enhanced XPA mRNA levels in cisplatin-resistant human ovarian cancer are not associated with XPA mutations or gene amplification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

Mutations in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

XPD/ERCC2 EXON 8 Polymorphisms: rarity and lack of significance in risk of squamous cell carcinoma of the head and neck

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

The human XPG gene: gene architecture, alternative splicing and single nucleotide polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

The non-catalytic function of XPG protein during dual incision in human nucleotide excision repair.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

Pharmacogenetics and cancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.07.024

10.1016/J.YGYNO.2007.07.024

7 January 2021

Identifiers

DOI

1 reference

25 July 2017

1 reference